Ensign Peak Advisors
IDXX icon

Ensign Peak Advisors’s Idexx Laboratories IDXX Stock Holding History

Ensign Peak Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Sell
30,147
-11,223
-27% -$6.29M 0.03% 359
2026
Q1 		$23.2M Sell
41,370
-8,325
-17% -$5.34M 0.04% 282
2025
Q4 		$33.6M Buy
49,695
+4,365
+10% +$2.97M 0.06% 232
2025
Q3 		$29M Buy
45,330
+5,080
+13% +$3.08M 0.05% 261
2025
Q2 		$21.6M Sell
40,250
-2,887
-7% -$1.38M 0.04% 302
2025
Q1 		$18.1M Buy
43,137
+16,133
+60% +$7.01M 0.03% 317
2024
Q4 		$11.2M Sell
27,004
-310
-1% -$136K 0.02% 443
2024
Q3 		$13.8M Sell
27,314
-6,692
-20% -$3.25M 0.02% 393
2024
Q2 		$16.6M Sell
34,006
-5,609
-14% -$2.82M 0.03% 342
2024
Q1 		$21.4M Buy
39,615
+6,376
+19% +$3.48M 0.04% 313
2023
Q4 		$18.4M Sell
33,239
-16,753
-34% -$7.87M 0.04% 308
2023
Q3 		$21.9M Sell
49,992
-7,441
-13% -$3.71M 0.05% 262
2023
Q2 		$28.8M Buy
57,433
+11,711
+26% +$5.61M 0.06% 242
2023
Q1 		$22.9M Buy
45,722
+2,087
+5% +$999K 0.05% 266
2022
Q4 		$17.8M Buy
43,635
+9,101
+26% +$3.53M 0.04% 316
2022
Q3 		$11.3M Sell
34,534
-4,257
-11% -$1.56M 0.03% 358
2022
Q2 		$13.6M Sell
38,791
-9,364
-19% -$3.82M 0.03% 324
2022
Q1 		$26.3M Sell
48,155
-8,272
-15% -$4.35M 0.05% 252
2021
Q4 		$37.2M Sell
56,427
-12,430
-18% -$7.8M 0.07% 227
2021
Q3 		$42.8M Buy
68,857
+10,308
+18% +$6.93M 0.09% 194
2021
Q2 		$37M Sell
58,549
-1,940
-3% -$1.07M 0.07% 222
2021
Q1 		$29.6M Sell
60,489
-28,987
-32% -$14.5M 0.06% 248
2020
Q4 		$44.7M Buy
89,476
+13,720
+18% +$6.14M 0.1% 174
2020
Q3 		$29.8M Buy
75,756
+8,670
+13% +$3.21M 0.08% 227
2020
Q2 		$22.1M Sell
67,086
-7,689
-10% -$2.23M 0.06% 267
2020
Q1 		$18.1M Buy
74,775
+43,148
+136% +$11.3M 0.06% 241
2019
Q4 		$8.26M Buy
+31,627
New +$8.33M 0.02% 494

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ensign Peak Advisors's IDXX Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Idexx Laboratories (IDXX) stake by 27% in Q2 2026, selling an estimated $6.29M and leaving 30,147 shares worth $15.9M. The position accounts for 0.03% of the portfolio, ranked #359.

Ensign Peak Advisors first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $44.7M in Q4 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ensign Peak Advisors held 30,147 shares of Idexx Laboratories worth $15.9M as of Q2 2026.
  • Ensign Peak Advisors sold 11,223 Idexx Laboratories shares in Q2 2026, an estimated $6.29M.
  • Idexx Laboratories made up 0.03% of Ensign Peak Advisors's portfolio in Q2 2026, its #359 holding.
  • Ensign Peak Advisors first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Idexx Laboratories position peaked at $44.7M in Q4 2020.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.